Fujiwara T - Search Results

1

Post-infarct treatment with an erythropoietin-gelatin hydrogel drug delivery system for cardiac repair.

Kobayashi H, Minatoguchi S, Yasuda S, Bao N, Kawamura I, Iwasa M, Yamaki T, Sumi S, Misao Y, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Tabata Y, Fujiwara H. Kobayashi H, et al. Among authors: fujiwara t, fujiwara h. Cardiovasc Res. 2008 Sep 1;79(4):611-20. doi: 10.1093/cvr/cvn154. Epub 2008 Jun 9. Cardiovasc Res. 2008. PMID: 18541523

2

Cyclophosphamide improves the function of post-infarct hearts by reducing old infarct area and accelerating the mobilization of CD34+ cells.

Misao Y, Arai M, Ohno T, Ushikoshi H, Takahashi T, Takemura G, Minatoguchi S, Fujiwara T, Fujiwara H. Misao Y, et al. Among authors: fujiwara t, fujiwara h. Circ J. 2005 Jun;69(6):763-5. doi: 10.1253/circj.69.763. Circ J. 2005. PMID: 15914960 Free article.

3

Bone marrow-derived myocyte-like cells and regulation of repair-related cytokines after bone marrow cell transplantation.

Misao Y, Takemura G, Arai M, Sato S, Suzuki K, Miyata S, Kosai K, Minatoguchi S, Fujiwara T, Fujiwara H. Misao Y, et al. Among authors: fujiwara t, fujiwara h. Cardiovasc Res. 2006 Feb 1;69(2):476-90. doi: 10.1016/j.cardiores.2005.11.001. Epub 2005 Dec 20. Cardiovasc Res. 2006. PMID: 16368087

4

Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF.

Misao Y, Takemura G, Arai M, Ohno T, Onogi H, Takahashi T, Minatoguchi S, Fujiwara T, Fujiwara H. Misao Y, et al. Among authors: fujiwara t, fujiwara h. Cardiovasc Res. 2006 Aug 1;71(3):455-65. doi: 10.1016/j.cardiores.2006.05.002. Epub 2006 May 9. Cardiovasc Res. 2006. PMID: 16769043

5

Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.

Li Y, Takemura G, Okada H, Miyata S, Maruyama R, Li L, Higuchi M, Minatoguchi S, Fujiwara T, Fujiwara H. Li Y, et al. Among authors: fujiwara t, fujiwara h. Cardiovasc Res. 2006 Sep 1;71(4):684-94. doi: 10.1016/j.cardiores.2006.06.003. Epub 2006 Jun 6. Cardiovasc Res. 2006. PMID: 16828072

6

Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.

Yasuda S, Kobayashi H, Iwasa M, Kawamura I, Sumi S, Narentuoya B, Yamaki T, Ushikoshi H, Nishigaki K, Nagashima K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S. Yasuda S, et al. Among authors: fujiwara t, fujiwara h. Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1558-65. doi: 10.1152/ajpheart.00712.2008. Epub 2009 Mar 13. Am J Physiol Heart Circ Physiol. 2009. PMID: 19286954 Free article.

7

Acarbose reduces myocardial infarct size by preventing postprandial hyperglycemia and hydroxyl radical production and opening mitochondrial KATP channels in rabbits.

Minatoguchi S, Zhang Z, Bao N, Kobayashi H, Yasuda S, Iwasa M, Sumi S, Kawamura I, Yamada Y, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H. Minatoguchi S, et al. Among authors: fujiwara t, fujiwara h. J Cardiovasc Pharmacol. 2009 Jul;54(1):25-30. doi: 10.1097/FJC.0b013e3181a98b53. J Cardiovasc Pharmacol. 2009. PMID: 19487955

8

Sustained release of erythropoietin using biodegradable gelatin hydrogel microspheres persistently improves lower leg ischemia.

Li L, Okada H, Takemura G, Esaki M, Kobayashi H, Kanamori H, Kawamura I, Maruyama R, Fujiwara T, Fujiwara H, Tabata Y, Minatoguchi S. Li L, et al. Among authors: fujiwara t, fujiwara h. J Am Coll Cardiol. 2009 Jun 23;53(25):2378-88. doi: 10.1016/j.jacc.2009.02.056. J Am Coll Cardiol. 2009. PMID: 19539150 Free article.

9

Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.

Kobayashi H, Yasuda S, Bao N, Iwasa M, Kawamura I, Yamada Y, Yamaki T, Sumi S, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S. Kobayashi H, et al. Among authors: fujiwara t, fujiwara h. J Cardiovasc Pharmacol. 2009 Dec;54(6):510-9. doi: 10.1097/FJC.0b013e3181bfac02. J Cardiovasc Pharmacol. 2009. PMID: 19755919

10

Antidiabetic drug voglibose is protective against ischemia-reperfusion injury through glucagon-like peptide 1 receptors and the phosphoinositide 3-kinase-Akt-endothelial nitric oxide synthase pathway in rabbits.

Iwasa M, Kobayashi H, Yasuda S, Kawamura I, Sumi S, Yamada Y, Shiraki T, Yamaki T, Ushikoshi H, Aoyama T, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S. Iwasa M, et al. Among authors: fujiwara t, fujiwara h. J Cardiovasc Pharmacol. 2010 Jun;55(6):625-34. doi: 10.1097/FJC.0b013e3181dcd240. J Cardiovasc Pharmacol. 2010. PMID: 20351564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,068 results

Search Page

Filters